Sugi Predict

Sugi Predict / Compounds / SCHEMBL21704885

SCHEMBL21704885

SCHEMBL21704885

N#Cc1cccc(-c2c3ccccc3c(-c3cccc(C#N)c3)c3cc4c(cc23)-c2ccc3c5ccc6c7c(-c8ccccc8)c8cccc9c%10ccccc%10c(c89)c7c7ccc(c8ccc-4c2c38)c5c67)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 6/20 0.37
▸ ALDH1A1 P00352 5/20 0.37
▸ CLK4 Q9HAZ1 5/20 0.37
▸ CYP2C19 P33261 5/20 0.37
▸ MEN1 O00255 4/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ HSD17B10 Q99714 4/20 0.37
▸ CYP3A4 P08684 4/20 0.37
▸ LMNA P02545 3/20 0.37
▸ CYP2D6 P10635 3/20 0.37
▸ TSHR P16473 3/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ ADORA2A P29274 2/20 0.37
▸ MAPK1 P28482 3/20 0.35
▸ USP2 O75604 2/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ HIF1A Q16665 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12682329 0.82 DPP4 (0.38) CYP1A2ALDH1A1CLK4CYP2C19MEN1
SCHEMBL21705106 0.80 CTDSP1 (0.32) CYP1A2CYP2C19CYP3A4CYP2C9
SCHEMBL21921271 0.79 MEN1 (0.37) CYP1A2ALDH1A1CLK4CYP2C19MEN1
SCHEMBL10038784 0.78 MEN1 (0.42) ALDH1A1MEN1KMT2ATSHRGABRA1
SCHEMBL21705078 0.78 ABCG2 (0.34) CYP1A2ALDH1A1CLK4CYP2C19MEN1
SCHEMBL13170768 0.78 ADORA2A (0.53) CYP1A2ALDH1A1CLK4CYP2C19MEN1
SCHEMBL21704886 0.77 GPR3 (0.31) CYP1A2ALDH1A1MAPT
SCHEMBL21705108 0.76 MAPK1 (0.34) CYP1A2ALDH1A1MEN1KMT2AHSD17B10
SCHEMBL21919792 0.76 MEN1 (0.39) CYP1A2ALDH1A1CLK4CYP2C19MEN1
SCHEMBL14242706 0.75 CYP1A2 (0.38) CYP1A2ALDH1A1CLK4CYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11370733-B2 Organic compound, organic light-emitting element, display device, imaging device, electronic device, illumination device, and moving object CANON KABUSHIKI KAISHA (JP) 2022-06-28 — — US disclosed
US-20200048171-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, IMAGING DEVICE, ELECTRONIC DEVICE, ILLUMINATION DEVICE, AND MOVING OBJECT CANON KABUSHIKI KAISHA (JP) 2020-02-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048171-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, IMAGING DEVICE, ELECTRONIC DEVICE, ILLUMINATION DEVICE, AND MOVING OBJECT OCIAD1, L1CAM, SPIN4 CYP1A2 1327/4885ALDH1A1 283/4885CLK4 3363/4885
US-11370733-B2 Organic compound, organic light-emitting element, display device, imaging device, electronic device, illumination device, and moving object OCIAD1, L1CAM, SPIN4 CYP1A2 1327/4885ALDH1A1 283/4885CLK4 3363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.